11 alpha-hydroxyprogesterone

Small moleculeexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • 11 alpha-hydroxyprogesterone
  • 11 beta-hydroxy-4-pregnen-3,20-dione
  • 11beta-hydroxyprogesterone
  • 11-hydroxyprogesterone
  • 11-hydroxyprogesterone, (11alpha,17alpha)-(+-)-isomer
  • 11-hydroxyprogesterone, (11alpha)-isomer
  • 11-hydroxyprogesterone, (11alpha)-(+-)-isomer
  • 11-hydroxyprogesterone, (11beta)-isomer
  • 11-hydroxyprogesterone, (9beta,10alpha,11alpha)-isomer
  • 11ohp compound
  • duralutin
  • gesterol
  • gesterol
  • hy-gestrone
  • hylutin
  • hyprogest
  • pergestron
  • pregn-4-ene-11 beta-ol-3,20-dione
  • pregn-4-ene-3,20-dione, 11-hydroxy-
  • pro-depo
  • prodrox